Offshoring contract manufacturing is not the only option for large
pharma firms looking to drive productivity and efficiency gains in
drug manufacturing, warns a new report from independent market
Despite its consolidation, the competitive consumable sector still
offers potential for rapid growth and better profits in the
biopharmaceutical industry, while contract bioprocessing services
will be increasingly in demand, according...
Oman Pharmaceutical Products (OPP) has entered its first
outsourcing partnership in Europe with Finnish company
Dragenopharm, providing the first step in its strategy to offer
contract manufacturing services globally.
Pharmaceutical companies are increasingly looking to retain their
internal focus on research and development (R&D) and marketing
while outsourcing their manufacturing processes, thus fueling a
growing demand for the manufacturing...
Medivative Technologies, a contract manufacturing and process
engineering services supplier to the life sciences and medical
device industries, has just been cleared for operations by the US
Food and Drug Administration (FDA).